iShares Global Healthcare ETF
0
Funds holding %
of 7,407 funds
–
Analysts bullish %
Fund manager confidence
Based on 2024 Q4 regulatory disclosures by fund managers ($100M+ AUM)
29% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 34
0% more funds holding
Funds holding: 271 [Q3] → 272 (+1) [Q4]
0.25% more ownership
Funds ownership: 72.35% [Q3] → 72.6% (+0.25%) [Q4]
0% more funds holding in top 10
Funds holding in top 10: 1 [Q3] → 1 (+0) [Q4]
15% less capital invested
Capital invested by funds: $3.13B [Q3] → $2.65B (-$480M) [Q4]
24% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 88
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $52K
Research analyst outlook
We haven’t received any recent analyst ratings for IXJ.
Financial journalist opinion
Negative
Zacks Investment Research
1 month ago
Recession Fears Looming? Secure Your Portfolio With These ETFs
Look at ETFs to safeguard your portfolio as declining consumer confidence, sluggish growth and persistent inflationary pressures increase the likelihood of the U.S. economy slipping into a recession in 2025.

Neutral
Seeking Alpha
1 month ago
Seeking Stocks With Vitality In The Volatile Healthcare Sector
Investors cooled to the healthcare sector in 2024, which dramatically trailed global and US equity markets for the year. any investors are now asking: how will the policy changes under a new US administration affect healthcare companies?

Negative
Seeking Alpha
2 months ago
IXJ: Healthcare Sector Dashboard For February
This article provides a top-down analysis of the healthcare sector, focusing on fundamental and momentum metrics. The healthcare sector is currently overvalued by about 13% relative to 11-year averages, with pharmaceuticals/biotechnology being the most overvalued. IXJ offers global healthcare exposure but is heavily weighted in U.S. companies and has underperformed XLV for 10 years.

Neutral
Zacks Investment Research
4 months ago
2025 Market Uncertainty? ETFs to Steady Your Portfolio
With escalating geopolitical tensions and unfavorable inflation trends in the U.S., increasing exposure to defensive sectors emerges as a smart investment strategy to navigate the potentially uncertain economic landscape of 2025.

Negative
Seeking Alpha
4 months ago
IXJ: Healthcare Sector Dashboard For November
The healthcare sector is overvalued by 18% relative to 11-year averages, with pharmaceuticals/biotechnology and healthcare equipment most overpriced. IXJ offers global healthcare exposure with lower concentration in top holdings compared to XLV, but still has 72% of assets in U.S. companies. 10 stocks cheaper than their peers in November.

Negative
Seeking Alpha
8 months ago
IXJ: Healthcare Sector Dashboard For August
Monthly article series showing healthcare industry metrics. The healthcare sector is overvalued by about 18% relative to 11-year averages. The most overvalued subsector is pharmaceuticals and biotechnology.

Negative
Seeking Alpha
10 months ago
IXJ: Growth Expected To Be Very Strong In The Next Few Years
iShares Global Healthcare ETF has underperformed the S&P 500 index in the past few years. IXJ has lower volatility and downside risk compared to the broader market. The healthcare sector is expected to have strong earnings growth in 2024 and 2025, making IXJ an attractive investment.
Neutral
Seeking Alpha
1 year ago
IXJ: Healthcare Sector Dashboard For March
The healthcare sector is overvalued by about 13% relative to 11-year averages, but overvaluation varies a lot across subsectors. Healthcare equipment has the worst value and quality scores. iShares Global Healthcare ETF is a global alternative to XLV.
Positive
Kiplinger
5 months ago
Best Healthcare ETFs To Buy Now
The best healthcare ETFs patch investors into an area of the market that offers both defensive properties and long-term growth.

Positive
InvestorPlace
1 year ago
Market Mayhem: 3 ETFs to Anchor Your Investments in 2024
ETF investing isn't necessarily the most fun way to allocate capital, but playing stock jockey isn't always a wise bet. Instead, using the top ETFs for 2024 as a portfolio anchor—whether retirement or taxable brokerage—helps offset and diversify the risk associated with individual stock picking.
Charts implemented using Lightweight Charts™